| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| RMD - ResMed Inc | HOLD | 0 @ USD 252.43 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 252.43. The average price that RMD shares were previous bought at was USD 251.403. The current market price is 0.4% higher than average price they were purchased at. The value of the holding in RMD has increased by USD 170,181 compared to the previous valuation of ResMed Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| IQV - IQVIA Holdings Inc | HOLD | 0 @ USD 218.53 | USD 0 | The current share valuation price of IQV based on adjusted close was USD 218.53. The average price that IQV shares were previous bought at was USD 190.649. The current market price is 14.6% higher than average price they were purchased at. The value of the holding in IQV has increased by USD 463,285 compared to the previous valuation of IQVIA Holdings Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 572.17 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 572.17. The average price that ISRG shares were previous bought at was USD 513.691. The current market price is 11.4% higher than average price they were purchased at. The value of the holding in ISRG has fallen by USD 718,771 compared to the previous valuation of Intuitive Surgical Inc |
| JNJ - Johnson & Johnson | HOLD | 0 @ USD 193.83 | USD 0 | The current share valuation price of JNJ based on adjusted close was USD 193.83. The average price that JNJ shares were previous bought at was USD 167.939. The current market price is 15.4% higher than average price they were purchased at. The value of the holding in JNJ has increased by USD 6,492,499 compared to the previous valuation of Johnson & Johnson however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| LH - Laboratory Corporation of America Holdings | HOLD | 0 @ USD 268.21 | USD 0 | The current share valuation price of LH based on adjusted close was USD 268.21. The average price that LH shares were previous bought at was USD 255.968. The current market price is 4.8% higher than average price they were purchased at. The value of the holding in LH has increased by USD 293,502 compared to the previous valuation of Laboratory Corporation of America Holdings however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| LLY - Eli Lilly and Company | HOLD | 0 @ USD 988.62 | USD 0 | The current share valuation price of LLY based on adjusted close was USD 988.62. The average price that LLY shares were previous bought at was USD 807.13. The current market price is 22.5% higher than average price they were purchased at. The value of the holding in LLY has increased by USD 8,690,782 compared to the previous valuation of Eli Lilly and Company however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| MCK - McKesson Corporation | HOLD | 0 @ USD 856.44 | USD 0 | The current share valuation price of MCK based on adjusted close was USD 856.44. The average price that MCK shares were previous bought at was USD 684.812. The current market price is 25.1% higher than average price they were purchased at. The value of the holding in MCK has fallen by USD 181,264 compared to the previous valuation of McKesson Corporation |
| MDT - Medtronic PLC | HOLD | 0 @ USD 95.4 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 95.4. The average price that MDT shares were previous bought at was USD 90.4631. The current market price is 5.5% higher than average price they were purchased at. The value of the holding in MDT has increased by USD 1,745,983 compared to the previous valuation of Medtronic PLC however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| MOH - MOH | HOLD | 0 @ USD 143.52 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 143.52. The average price that MOH shares were previous bought at was USD 245.737. The current market price is -41.6% lower than average price they were purchased at. The value of the holding in MOH has increased by USD 71,128 compared to the previous valuation of MOH however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | HOLD | 0 @ USD 143.52 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 143.52. The average price that MOH shares were previous bought at was USD 245.737. The current market price is -41.6% lower than average price they were purchased at. The value of the holding in MOH has increased by USD 71,128 compared to the previous valuation of LVMH Moët Hennessy - Louis Vuitton Société Européenne however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| MRK - Marks Electrical Group PLC | HOLD | 0 @ USD 90.95 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 90.95. The average price that MRK shares were previous bought at was USD 87.9838. The current market price is 3.4% higher than average price they were purchased at. The value of the holding in MRK has increased by USD 5,219,151 compared to the previous valuation of Marks Electrical Group PLC however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| MRK - Merck & Company Inc | HOLD | 0 @ USD 90.95 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 90.95. The average price that MRK shares were previous bought at was USD 87.9838. The current market price is 3.4% higher than average price they were purchased at. The value of the holding in MRK has increased by USD 5,219,151 compared to the previous valuation of Merck & Company Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| MRNA - Moderna Inc | HOLD | 0 @ USD 26.41 | USD 0 | The current share valuation price of MRNA based on adjusted close was USD 26.41. The average price that MRNA shares were previous bought at was USD 30.5439. The current market price is -13.5% lower than average price they were purchased at. The value of the holding in MRNA has increased by USD 282,622 compared to the previous valuation of Moderna Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| MTD - Mettler-Toledo International Inc | HOLD | 0 @ USD 1445.06 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1445.06. The average price that MTD shares were previous bought at was USD 1275.07. The current market price is 13.3% higher than average price they were purchased at. The value of the holding in MTD has increased by USD 128,785 compared to the previous valuation of Mettler-Toledo International Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| MTD - AMUNDI EUR GOV 710 | HOLD | 0 @ USD 1445.06 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1445.06. The average price that MTD shares were previous bought at was USD 1275.07. The current market price is 13.3% higher than average price they were purchased at. The value of the holding in MTD has increased by USD 128,785 compared to the previous valuation of AMUNDI EUR GOV 710 however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| PFE - Pfizer Inc | HOLD | 0 @ USD 25.51 | USD 0 | The current share valuation price of PFE based on adjusted close was USD 25.51. The average price that PFE shares were previous bought at was USD 25.2622. The current market price is 1.0% higher than average price they were purchased at. The value of the holding in PFE has increased by USD 3,171,003 compared to the previous valuation of Pfizer Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| PODD - Insulet Corporation | HOLD | 0 @ USD 326.28 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 326.28. The average price that PODD shares were previous bought at was USD 293.794. The current market price is 11.1% higher than average price they were purchased at. The value of the holding in PODD has increased by USD 206,863 compared to the previous valuation of Insulet Corporation however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| REGN - Regeneron Pharmaceuticals Inc | HOLD | 0 @ USD 674.55 | USD 0 | The current share valuation price of REGN based on adjusted close was USD 674.55. The average price that REGN shares were previous bought at was USD 643.966. The current market price is 4.7% higher than average price they were purchased at. The value of the holding in REGN has increased by USD 1,004,010 compared to the previous valuation of Regeneron Pharmaceuticals Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| INCY - Incyte Corporation | HOLD | 0 @ USD 108.16 | USD 0 | The current share valuation price of INCY based on adjusted close was USD 108.16. The average price that INCY shares were previous bought at was USD 77.7732. The current market price is 39.1% higher than average price they were purchased at. The value of the holding in INCY has increased by USD 178,921 compared to the previous valuation of Incyte Corporation however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| RVTY - Revvity Inc. | HOLD | 0 @ USD 94.31 | USD 0 | The current share valuation price of RVTY based on adjusted close was USD 94.31. The average price that RVTY shares were previous bought at was USD 103.065. The current market price is -8.5% lower than average price they were purchased at. The value of the holding in RVTY has increased by USD 118,611 compared to the previous valuation of Revvity Inc. however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| SOLV - Solventum Corp. | HOLD | 0 @ USD 73.88 | USD 0 | The current share valuation price of SOLV based on adjusted close was USD 73.88. The average price that SOLV shares were previous bought at was USD 72.8089. The current market price is 1.5% higher than average price they were purchased at. The value of the holding in SOLV has increased by USD 152,451 compared to the previous valuation of Solventum Corp. however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| STE - STERIS plc | HOLD | 0 @ USD 266.7 | USD 0 | The current share valuation price of STE based on adjusted close was USD 266.7. The average price that STE shares were previous bought at was USD 232.746. The current market price is 14.6% higher than average price they were purchased at. The value of the holding in STE has increased by USD 130,648 compared to the previous valuation of STERIS plc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| SYK - Stryker Corporation | HOLD | 0 @ USD 363.7 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 363.7. The average price that SYK shares were previous bought at was USD 376.34. The current market price is -3.4% lower than average price they were purchased at. The value of the holding in SYK has increased by USD 1,487,196 compared to the previous valuation of Stryker Corporation however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| TECH - Bio-Techne Corp | HOLD | 0 @ USD 59.18 | USD 0 | The current share valuation price of TECH based on adjusted close was USD 59.18. The average price that TECH shares were previous bought at was USD 60.4746. The current market price is -2.1% lower than average price they were purchased at. The value of the holding in TECH has increased by USD 133,418 compared to the previous valuation of Bio-Techne Corp however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| TMO - Time Out Group plc | HOLD | 0 @ USD 586.49 | USD 0 | The current share valuation price of TMO based on adjusted close was USD 586.49. The average price that TMO shares were previous bought at was USD 510.244. The current market price is 14.9% higher than average price they were purchased at. The value of the holding in TMO has increased by USD 1,904,809 compared to the previous valuation of Time Out Group plc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| UHS - Universal Health Services Inc | HOLD | 0 @ USD 224.41 | USD 0 | The current share valuation price of UHS based on adjusted close was USD 224.41. The average price that UHS shares were previous bought at was USD 191.028. The current market price is 17.5% higher than average price they were purchased at. The value of the holding in UHS has increased by USD 50,272 compared to the previous valuation of Universal Health Services Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| UNH - UnitedHealth Group Incorporated | HOLD | 0 @ USD 327.45 | USD 0 | The current share valuation price of UNH based on adjusted close was USD 327.45. The average price that UNH shares were previous bought at was USD 422.731. The current market price is -22.5% lower than average price they were purchased at. The value of the holding in UNH has increased by USD 2,642,997 compared to the previous valuation of UnitedHealth Group Incorporated however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| VRTX - Vertex Pharmaceuticals Inc | HOLD | 0 @ USD 429.22 | USD 0 | The current share valuation price of VRTX based on adjusted close was USD 429.22. The average price that VRTX shares were previous bought at was USD 442.217. The current market price is -2.9% lower than average price they were purchased at. The value of the holding in VRTX has increased by USD 1,023,970 compared to the previous valuation of Vertex Pharmaceuticals Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| VTRS - Viatris Inc | HOLD | 0 @ USD 11.2 | USD 0 | The current share valuation price of VTRS based on adjusted close was USD 11.2. The average price that VTRS shares were previous bought at was USD 10.2639. The current market price is 9.1% higher than average price they were purchased at. The value of the holding in VTRS has increased by USD 590,593 compared to the previous valuation of Viatris Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| WAT - Waters Corporation | HOLD | 0 @ USD 386.14 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 386.14. The average price that WAT shares were previous bought at was USD 346.063. The current market price is 11.6% higher than average price they were purchased at. The value of the holding in WAT has increased by USD 282,296 compared to the previous valuation of Waters Corporation however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| WAT - MULETFWATIMETFP | HOLD | 0 @ USD 386.14 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 386.14. The average price that WAT shares were previous bought at was USD 346.063. The current market price is 11.6% higher than average price they were purchased at. The value of the holding in WAT has increased by USD 282,296 compared to the previous valuation of MULETFWATIMETFP however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| WST - West Pharmaceutical Services Inc | HOLD | 0 @ USD 277.41 | USD 0 | The current share valuation price of WST based on adjusted close was USD 277.41. The average price that WST shares were previous bought at was USD 255.094. The current market price is 8.7% higher than average price they were purchased at. The value of the holding in WST has increased by USD 68,907 compared to the previous valuation of West Pharmaceutical Services Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 88.5 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 88.5. The average price that ZBH shares were previous bought at was USD 102.625. The current market price is -13.8% lower than average price they were purchased at. The value of the holding in ZBH has fallen by USD 22,709 compared to the previous valuation of Zimmer Biomet Holdings Inc |
| ZTS - Zoetis Inc | HOLD | 0 @ USD 120.12 | USD 0 | The current share valuation price of ZTS based on adjusted close was USD 120.12. The average price that ZTS shares were previous bought at was USD 156.712. The current market price is -23.3% lower than average price they were purchased at. The value of the holding in ZTS has increased by USD 73,004 compared to the previous valuation of Zoetis Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| CRL - Creightons Plc | HOLD | 0 @ USD 173.5 | USD 0 | The current share valuation price of CRL based on adjusted close was USD 173.5. The average price that CRL shares were previous bought at was USD 165.889. The current market price is 4.6% higher than average price they were purchased at. The value of the holding in CRL has increased by USD 110,287 compared to the previous valuation of Creightons Plc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| ABBV - AbbVie Inc | HOLD | 0 @ USD 225.17 | USD 0 | The current share valuation price of ABBV based on adjusted close was USD 225.17. The average price that ABBV shares were previous bought at was USD 202.777. The current market price is 11.0% higher than average price they were purchased at. The value of the holding in ABBV has increased by USD 5,676,382 compared to the previous valuation of AbbVie Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 127 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 127. The average price that ABT shares were previous bought at was USD 128.831. The current market price is -1.4% lower than average price they were purchased at. The value of the holding in ABT has increased by USD 961,135 compared to the previous valuation of Abbott Laboratories however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| ALGN - Align Technology Inc | HOLD | 0 @ USD 144.49 | USD 0 | The current share valuation price of ALGN based on adjusted close was USD 144.49. The average price that ALGN shares were previous bought at was USD 168.683. The current market price is -14.3% lower than average price they were purchased at. The value of the holding in ALGN has increased by USD 211,331 compared to the previous valuation of Align Technology Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| AMGN - Amgen Inc | HOLD | 0 @ USD 338.45 | USD 0 | The current share valuation price of AMGN based on adjusted close was USD 338.45. The average price that AMGN shares were previous bought at was USD 299.275. The current market price is 13.1% higher than average price they were purchased at. The value of the holding in AMGN has increased by USD 3,960,910 compared to the previous valuation of Amgen Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| BAX - Baxter International Inc | HOLD | 0 @ USD 18.25 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 18.25. The average price that BAX shares were previous bought at was USD 28.5562. The current market price is -36.1% lower than average price they were purchased at. The value of the holding in BAX has increased by USD 127,896 compared to the previous valuation of Baxter International Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 189.02 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 189.02. The average price that BDX shares were previous bought at was USD 206.433. The current market price is -8.4% lower than average price they were purchased at. The value of the holding in BDX has increased by USD 1,050,986 compared to the previous valuation of Becton Dickinson and Company however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| BIIB - Biogen Inc | HOLD | 0 @ USD 159.56 | USD 0 | The current share valuation price of BIIB based on adjusted close was USD 159.56. The average price that BIIB shares were previous bought at was USD 142.501. The current market price is 12.0% higher than average price they were purchased at. The value of the holding in BIIB has increased by USD 240,557 compared to the previous valuation of Biogen Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| BMY - Bloomsbury Publishing Plc | HOLD | 0 @ USD 48.72 | USD 0 | The current share valuation price of BMY based on adjusted close was USD 48.72. The average price that BMY shares were previous bought at was USD 51.7502. The current market price is -5.9% lower than average price they were purchased at. The value of the holding in BMY has increased by USD 1,477,218 compared to the previous valuation of Bloomsbury Publishing Plc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 102.5 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 102.5. The average price that BSX shares were previous bought at was USD 99.9939. The current market price is 2.5% higher than average price they were purchased at. The value of the holding in BSX has increased by USD 1,172,109 compared to the previous valuation of Boston Scientific Corporation however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 102.5 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 102.5. The average price that BSX shares were previous bought at was USD 99.9939. The current market price is 2.5% higher than average price they were purchased at. The value of the holding in BSX has increased by USD 1,172,109 compared to the previous valuation of MULSTRXSSXIMETFP however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| CAH - Cardinal Health Inc | HOLD | 0 @ USD 204.81 | USD 0 | The current share valuation price of CAH based on adjusted close was USD 204.81. The average price that CAH shares were previous bought at was USD 144.858. The current market price is 41.4% higher than average price they were purchased at. The value of the holding in CAH has fallen by USD 73,249 compared to the previous valuation of Cardinal Health Inc |
| CI - Cigna Corp | HOLD | 0 @ USD 268 | USD 0 | The current share valuation price of CI based on adjusted close was USD 268. The average price that CI shares were previous bought at was USD 303.107. The current market price is -11.6% lower than average price they were purchased at. The value of the holding in CI has increased by USD 1,309,055 compared to the previous valuation of Cigna Corp however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| CNC - Concurrent Technologies Plc | HOLD | 0 @ USD 35.36 | USD 0 | The current share valuation price of CNC based on adjusted close was USD 35.36. The average price that CNC shares were previous bought at was USD 47.6821. The current market price is -25.8% lower than average price they were purchased at. The value of the holding in CNC has increased by USD 257,706 compared to the previous valuation of Concurrent Technologies Plc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| COO - The Cooper Companies, Inc. Common Stock | HOLD | 0 @ USD 71.74 | USD 0 | The current share valuation price of COO based on adjusted close was USD 71.74. The average price that COO shares were previous bought at was USD 80.9553. The current market price is -11.4% lower than average price they were purchased at. The value of the holding in COO has increased by USD 101,229 compared to the previous valuation of The Cooper Companies, Inc. Common Stock however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| COR - Cencora Inc. | HOLD | 0 @ USD 365.08 | USD 0 | The current share valuation price of COR based on adjusted close was USD 365.08. The average price that COR shares were previous bought at was USD 294.207. The current market price is 24.1% higher than average price they were purchased at. The value of the holding in COR has increased by USD 41,462 compared to the previous valuation of Cencora Inc. however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| A - Agilent Technologies Inc | HOLD | 0 @ USD 149.42 | USD 0 | The current share valuation price of A based on adjusted close was USD 149.42. The average price that A shares were previous bought at was USD 128.554. The current market price is 16.2% higher than average price they were purchased at. The value of the holding in A has increased by USD 432,831 compared to the previous valuation of Agilent Technologies Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| CVS - CVS Health Corp | HOLD | 0 @ USD 79.87 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 79.87. The average price that CVS shares were previous bought at was USD 68.2483. The current market price is 17.0% higher than average price they were purchased at. The value of the holding in CVS has increased by USD 1,469,750 compared to the previous valuation of CVS Health Corp however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| DGX - Quest Diagnostics Incorporated | HOLD | 0 @ USD 188.85 | USD 0 | The current share valuation price of DGX based on adjusted close was USD 188.85. The average price that DGX shares were previous bought at was USD 173.58. The current market price is 8.8% higher than average price they were purchased at. The value of the holding in DGX has increased by USD 249,605 compared to the previous valuation of Quest Diagnostics Incorporated however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 215.79 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 215.79. The average price that DHR shares were previous bought at was USD 211.945. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in DHR has increased by USD 1,461,930 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 215.79 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 215.79. The average price that DHR shares were previous bought at was USD 211.945. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in DHR has increased by USD 1,461,930 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| DVA - DaVita HealthCare Partners Inc | HOLD | 0 @ USD 122.27 | USD 0 | The current share valuation price of DVA based on adjusted close was USD 122.27. The average price that DVA shares were previous bought at was USD 143.507. The current market price is -14.8% lower than average price they were purchased at. The value of the holding in DVA has increased by USD 37,372 compared to the previous valuation of DaVita HealthCare Partners Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| DXCM - DexCom Inc | HOLD | 0 @ USD 58.13 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 58.13. The average price that DXCM shares were previous bought at was USD 75.6423. The current market price is -23.2% lower than average price they were purchased at. The value of the holding in DXCM has increased by USD 642,520 compared to the previous valuation of DexCom Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 315.25 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 315.25. The average price that ELV shares were previous bought at was USD 368.884. The current market price is -14.5% lower than average price they were purchased at. The value of the holding in ELV has increased by USD 1,283,539 compared to the previous valuation of Elevance Health Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 315.25 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 315.25. The average price that ELV shares were previous bought at was USD 368.884. The current market price is -14.5% lower than average price they were purchased at. The value of the holding in ELV has increased by USD 1,283,539 compared to the previous valuation of Elevance Health Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 85.16 | USD 0 | The current share valuation price of EW based on adjusted close was USD 85.16. The average price that EW shares were previous bought at was USD 74.4203. The current market price is 14.4% higher than average price they were purchased at. The value of the holding in EW has increased by USD 316,013 compared to the previous valuation of Edwards Lifesciences Corp however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 73.41 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 73.41. The average price that GEHC shares were previous bought at was USD 78.8612. The current market price is -6.9% lower than average price they were purchased at. The value of the holding in GEHC has fallen by USD 15,875 compared to the previous valuation of GE HealthCare Technologies Inc. |
| GILD - Guild Esports Plc | HOLD | 0 @ USD 122.56 | USD 0 | The current share valuation price of GILD based on adjusted close was USD 122.56. The average price that GILD shares were previous bought at was USD 109.717. The current market price is 11.7% higher than average price they were purchased at. The value of the holding in GILD has increased by USD 2,723,783 compared to the previous valuation of Guild Esports Plc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| HCA - HCA Holdings Inc | HOLD | 0 @ USD 462.31 | USD 0 | The current share valuation price of HCA based on adjusted close was USD 462.31. The average price that HCA shares were previous bought at was USD 374.802. The current market price is 23.3% higher than average price they were purchased at. The value of the holding in HCA has increased by USD 245,255 compared to the previous valuation of HCA Holdings Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| HOLX - Hologic Inc | HOLD | 0 @ USD 74.6 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 74.6. The average price that HOLX shares were previous bought at was USD 67.6329. The current market price is 10.3% higher than average price they were purchased at. The value of the holding in HOLX has increased by USD 33,085 compared to the previous valuation of Hologic Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| HSIC - Henry Schein Inc | HOLD | 0 @ USD 73.22 | USD 0 | The current share valuation price of HSIC based on adjusted close was USD 73.22. The average price that HSIC shares were previous bought at was USD 70.4247. The current market price is 4.0% higher than average price they were purchased at. The value of the holding in HSIC has increased by USD 11,288 compared to the previous valuation of Henry Schein Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| HUM - Hummingbird Resources PLC | HOLD | 0 @ USD 243.47 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 243.47. The average price that HUM shares were previous bought at was USD 266.683. The current market price is -8.7% lower than average price they were purchased at. The value of the holding in HUM has increased by USD 301,823 compared to the previous valuation of Hummingbird Resources PLC however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| HUM - Humana Inc | HOLD | 0 @ USD 243.47 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 243.47. The average price that HUM shares were previous bought at was USD 266.683. The current market price is -8.7% lower than average price they were purchased at. The value of the holding in HUM has increased by USD 301,823 compared to the previous valuation of Humana Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 712.47 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 712.47. The average price that IDXX shares were previous bought at was USD 538.225. The current market price is 32.4% higher than average price they were purchased at. The value of the holding in IDXX has increased by USD 114,301 compared to the previous valuation of IDEXX Laboratories Inc however if the holding was sold on 2025-11-11 this would crystalise an overall loss. |